4.7 Letter

A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation

Journal

JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 142, Issue 6, Pages 1749-1752

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jid.2021.07.190

Keywords

-

Categories

Funding

  1. National Institutes of Health (Bethesda, MD) [T32HL098129]
  2. National Institutes of Health Clinical and Translational Science Award at New York University [UL1TR001445, KL2TR001446, TL1TR001447]
  3. American Heart Association Career Development Grant [18CDA34080540, 18CDA34110203AHA]
  4. Dermatology Foundation Research Grant
  5. National Psoriasis Foundation Bridge Grant
  6. American Society of Hematology [18-A0-00-1001884]
  7. National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR074500]
  8. Riley Family Foundation
  9. Beatriz Snyder Foundation
  10. Rheumatology Research Foundation
  11. National Psoriasis Foundation Diagnostic Challenge Grant
  12. National Institutes of Health grants [R01HL139909, R35HL144993]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available